Tag: terumo aortic
Terumo Aortic announces the first commercial implant of Fenestrated TREO in...
This advertorial is sponsored by Terumo Aortic.
On 9 April 2024, a significant milestone was achieved as Terumo Aortic introduced the first implantation of the...
Terumo Aortic receives prestigious King’s Award for Innovation
Terumo Aortic today announced that it has received the prestigious King’s Award for Enterprise in the Innovation category for its global custom solutions programme....
Terumo Aortic announces PMDA approval for Thoraflex Hybrid in Japan
Terumo Aortic have today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has granted approval of the Thoraflex Hybrid frozen elephant...
Terumo Aortic announces launch of global Thoraflex Hybrid EXTEND study
Terumo Aortic announced in a press release the launch of the company’s global post-approval study (PAS) known as EXTEND for Thoraflex Hybrid, the only...
Vascular News’ top 10 most popular stories of April 2023
April's top 10 sees a product announcement from Terumo Aortic take the top spot, with highlights from the 2023 Charing Cross (CX) International Symposium...
Terumo Aortic announces FDA approval of dissection and transection indication expansion...
Terumo Aortic today announced that the US Food and Drug Administration (FDA) has granted approval of the RelayPro thoracic stent graft device for the...
Terumo Aortic announces first implant of custom-made thoracoabdominal hybrid device in...
Terumo Aortic today announced the first North American implant of a custom-made hybrid device, Thoracoflo.
A press release notes that the device is used to...
Terumo Aortic announces new technology add-on payment for Thoraflex Hybrid device...
Terumo Aortic today announced that the US Centers for Medicare and Medicaid Services (CMS) has granted approval of a new technology add-on payment (NTAP)...
Vascular News’ top 10 most popular stories of July 2022
July's top 10 most popular items include more from this year's Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM 2022; 15–18 June, Boston,...
Terumo Aortic announces first commercial implant of the Thoraflex Hybrid device...
Following the recent approval by the US Food and Drug Administration (FDA) of the Thoraflex Hybrid frozen elephant trunk (FET) device for the treatment...
Vascular News’ top 10 most popular stories of December 2021
Highlights from the UK Vascular Societies’ Annual Scientific Meeting (VSASM 2021; 1–3 December, Manchester, UK), a VOYAGER PAD subanalysis, and Cordis' appointment of a...
Terumo Aortic announces PMDA approval for RelayPro endovascular device in Japan
Terumo Aortic has announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has granted approval of the RelayPro thoracic stent graft system for...
Terumo Aortic announces launch and first commercial use of Aortic Balloon...
Terumo Aortic has announced the launch and first commercial case of the Aortic Balloon in the USA. The device assists physicians in the expansion...
Vascular News’ top 10 most popular stories of October 2021
New data from a head-to-head, randomised trial comparing vascular closure devices, highlights from CX Aortic Vienna 2021 (5–7 October, broadcast) and an interview with past Society...
Terumo Aortic announces PMDA approval and first commercial implant of Treo...
Following the recent approval by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) of the Treo abdominal aortic stent graft system for sale in...
Vascular News’ top 10 most popular stories of September 2021
September's top 10 features five-year ACST-2 results, a new tool to assess amputation risk following popliteal vascular injury, and an interview highlighting the questions...
Terumo Aortic announces launch of landmark global surgical graft study
Terumo Aortic has announced the launch of the company’s global surgical graft study known as PANTHER. This study is a prospective and retrospective, multicentre,...
Terumo Aortic announces first implant of landmark thoracoabdominal hybrid device
Terumo Aortic has announced the successful implantation of the company’s first custom-made thoracoabdominal hybrid device to treat thoracoabdominal aortic disease.
The world’s first thoracoabdominal repair...
Terumo Aortic announces first commercial implants of RelayPro endovascular device in...
Following the recent approval by the US Food and Drug Administration (FDA) of the RelayPro thoracic stent graft system for the treatment of patients...
Vascular News’ top 10 most popular stories of August 2021
Research presented at the Society for Vascular Surgery’s Vascular Annual Meeting (SVS VAM 2021; 18–21 August, San Diego, USA and online)—including new VOYAGER PAD...
Terumo Aortic announces US FDA approval for RelayPro endovascular device
Terumo Aortic has announced that the US Food and Drug Administration (FDA) has granted approval of its RelayPro thoracic stent-graft system for sale in...
Primary endpoint results from Treo pivotal study published
Following recent approval by the US Food and Drug Administration (FDA) of the Treo abdominal aortic stent graft system for the treatment of patients...
RelayPro US transection pivotal study completes enrolment
Terumo Aortic has announced completion of enrolment of the RelayPro traumatic injury (RelayPro-T) investigational device exemption (IDE) study in the USA. RelayPro is a...
Terumo Aortic announces mid-term results with real-world use of the RelayPlus...
Terumo Aortic has announced the midterm results from the RelayPlus thoracic stent graft system post-approval study, revealing low operative mortality and morbidity—supporting its use...
Terumo Aortic announces FDA approval for Treo endovascular device
Terumo Aortic has announced that the US Food and Drug Administration (FDA) has granted approval of the Treo abdominal aortic stent-graft system for sale...
Terumo Aortic announces US FDA breakthrough device designation for Thoraflex Hybrid...
Terumo Aortic today announced that the US Food and Drug Administration (FDA) has granted breakthrough device designation for its Thoraflex Hybrid stented device for...
Terumo Aortic announces launch of industry-first global endovascular registry
Terumo Aortic has announced the launch of the company’s global endovascular registry known as TiGER (Terumo Aortic Global Endovascular Registry).
TiGER is a global, prospective,...
Terumo Aortic announces completion of enrolment of RelayPro US pivotal study
Terumo Aortic has announced the completion of enrolment of the RelayPro pivotal study in the USA. RelayPro is a low profile, next generation thoracic...
Terumo Aortic acquires Serom Medical Technology
Terumo Aortic has announced the acquisition of Serom Medical Technology S.r.l. by Vascutek Ltd and the subsequent merger with Bolton Medical S.r.l. in Italy.
Serom...
RelayBranch early feasibility study begins enrolment
The first two patients have been successfully enrolled in the RelayBranch Early Feasibility Study. This trial will assess the safety and efficacy of the...
CX 2018: Terumo Aortic launches RelayPro thoracic stent graft in Europe
Terumo Aortic have announced the European limited market release of the RelayPro thoracic stent graft system at the 2018 Charing Cross Symposium (CX; 24–27...
Vascutek and Bolton Medical merge as “Terumo Aortic”
Vascutek and Bolton Medical, subsidiaries of Terumo Corporation of Japan, have combined into Terumo Aortic. Combining the aortic companies into a single business, Terumo...
